<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=348185225613720&amp;ev=PageView&amp;noscript=1">
COVID_Surveillance_LP-Hero

GENEWIZ offers COVID-19 surveillance through sub-strain identification​

In response to emerging COVID-19 sub-strains, GENEWIZ has developed workflows specifically tailored for their identification. Mutations within the genome of sub-strains may result in differences in infectability, severity, and vaccine response, therefore characterizing and tracking them is essential for successful surveillance and prevention.

With our global presence, state-of-the-art facilities, and highly-qualified scientific team, we are well-equipped to support the scale and speed needed for your COVID-19 sequencing and surveillance initiatives. 

Why choose GENEWIZ?
  • Industry-Leading Turnaround Time with options for expedited sample processing & sequencing
  • Global Network of Laboratories with state-of-the-art facilities, including a CAP/CLIA laboratory
  • Complete Solutions Workflow from nucleic acid extraction to data analysis
  • Dedicated Study Manager to facilitate project coordination and technical support
Contact us:
To speak with an expert or discuss your specific COVID-19 project, please fill out the following form:

For technical support questions, please contact our team of experts

CLIA@genewiz.com

Germany: +49 (0)341 520 122-41 | United Kingdom: +44 (0)1279 873 837 | France: 0811 230001 | All Other European Locations: +49 (0)341 520 122-41